Hematologia Clínica

Barcelona 08003

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis

Studies at this site

• KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF — Status unconfirmed